Hurley Capital »

Vyne Therapeutics shares owned by Hurley Capital

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Hurley Capital from 13F filings

Historical chart of Hurley Capital investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Hurley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Hurley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $325k 561 579.32

More positions owned by Hurley Capital

Ishares Ibonds 2026 Termhigh Yield Uit Exchange Traded (IBHF)
Vanguard Index Fds Vanguard Value Etf Formerly Vanguard Index Tr Equities (VTV)
Sprott Physical Silver E Closed End Mutl Fund (PSLV)
Vanguard Russell 1000 Growth Etf Uit Exchange Traded (VONG)
Vanguard Inter-term Treas Index Uit Exchange Traded (VGIT)
Vanguard Index Funds S&p 500 Etf Usd Equities (VOO)
Enterprise Prods Part Limited Partnershp (EPD)
Schwab International Equity Etf Uit Exchange Traded (SCHF)
Alphabet Inc Cap Stk Cl A Equities (GOOGL)
Ishares Tr Ibonds 2027 Term Equities (IBHG)
Select Sector Spdr Trust State Street Technology Select Sector Spdr Etf Equities (XLK)
Morgan Stanley Common Stock (MS)
Schwab Strategic Tr Us Large-cap Etf Equities (SCHX)
Spdr S&p 500 Etf Uit Exchange Traded (SPY)
Schwab Us Large Cap Growth Etf Uit Exchange Traded (SCHG)

View all positions for Hurley Capital

Top funds holding Vyne Therapeutics

None
Frigate Ventures
Nantahala Capital Management
Baker Bros. Advisors
Acadian Asset Management
KVP Capital Advisors
Vanguard Group
Ikarian Capital
ADAR1 Capital Management
Geode Capital Management
Two Sigma Investments
Susquehanna International
Rangeley Capital
Boothbay Fund Management
XTX Topco

View all funds holding Vyne Therapeutics